References
- Lotan R. Receptor-independent induction of apoptosis by synthetic retinoids. J Biol Regul Homeost Agents 2003; 17 (1): 13–28.
- Garattini E, Gianni M, Terao M. Retinoid related mole-cules an emerging class of apoptotic agents with promising therapeutic potential in oncology: pharmacological activity and mechanisms of action. Curr Pharm Des 2004; 10 (4): 433–48.
- Cincinelli R, DaIla Valle S, Merlini L, et al. A novel atypical retinoid endowed with proapoptotic and antitumor activity. J Med Chem 2003; 46 (6): 909–12.
- Garattini E, Parrella E, Diomede L, et al. ST1926 a novel and orally active retinoid related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis. Blood 2004; 103 (1): 194–207.
- ZUCO V, Zanchi C, Cassinelli G, et al. Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid. Cell Death Diff 2004; 11: 280–289.
- Pisano C, Vesci L, Zanier R, et al. A novel atypical retinoid endowed with proapoptotic and antitumor activity. Proc. 93'd AACR Annual Meeting July, 11-14, 2003 - Washington, DC (USA) - Abstract # R2702.
- Pisano C, Vesci L, Fodera R, et al. Antitumor Activity of a Novel Adamantyl Retinoid: Molecular and Pharmacological Characterization. Proc. AACR-NCI-EORTC International Conference “Molecular Targets and Cancer Therapeutics” November 17-21, 2003 - Boston, (USA) - Abstract # C9.
- Pisano C, Vesci L, Bucci F, et al. Increases in host-mediated responses to tumor xenograft by ST 1926, a novel Adamantyl retinoid. Proc. 1st ISC International Conference on “Cancer Therapeutics Molecular Targets, Pharmacology and Clinical Applications” February, 19-21, 2004 - Florence, Italy - Abstract #25.